Winning awards

Usually, with a company, all your trying to do is work out if earnings are “better or worse than expected”.

But the inputs to that easy-to-say-hard-to-do idea are the analytical legwork that’s required.

With QBE, we note the winning of awards: e.g. “Green insurer of the year” for the fourth year running. You (as the investor) want to invest in “Quality companies with Good Growth prospects”, as part of a dedicated factor premia tilt.

Hence, companies that are receiving industry accolades are usually a good thing for evidencing that quality.

Anyway, back to the “better than expected” stuff.

Combined operating ratios

Despite putting out a result that mildly disappointed the market, particularly relative to implied FY guidance, management seemed to highlight that things are tracking well. Here’s the prepared, introductory result. That’s good to hear.

The combined operating ratio (COR) was 97.6%. Ex-catastrophic claims, the underlying COR was in the low-mid 90s, which is a stronger result. Those cat claims were, well, catastrophic, as the below helps describe.

Now, the easy rebuttal is “cat claims are a part of doing business, and that cost has gone up by frequency and magnitude in a world of climate change, and so you shouldn’t look at normalised numbers”.

That is a very valid point. Gross written premiums are going up by 10% per annum because of this global repricing of risk. They may not have gotten it precisely right, but they are headed in the right direction.

So, it’s not like it is uncompensated risk.

However, the overall result of a high actual COR of 97.6% does have bearing on “will they hit guidance” as discussed below.


Guidance for the full-year COR remains at 94.5%, which means the 2H is expected to be very strong at 92%.

The problem here is that does require a material enough step up in the 2H. Siddarth below covers off this uplift. It is expected, but would still be a bit unusual, as an uplift.

Inder, above, doesn’t push back on this hurdle, but sticks to the good momentum in the business from rate and volume growth, and inflation moderating, and, to a lesser degree, the underlying business ex-cat claims that is doing well enough.

So that’s really the big one. Either Siddharth’s concerns are valid, or Inder’s answers are correct. And that’s what the market was worried about, regarding guidance.

Investment income

Just as with SUN, out earlier last week, the investment income is a huge part of the story. Running yields at ~5% are very, very attractive in the current environment.


Turning to longer-dated productivity initiatives, my old colleague Simon, below, from AMP Capital days touched on the role that AI can play in helping streamline the underwriting process. The response from management is what we expect, namely excitement. It’s worth reading.

We’ve long thought that finance, e.g. insurance and banking, and perhaps after that, legal, are the areas most amenable to AI, and QBE’s commentary here is encouraging from a longer run perspective.


So, overall, the result summarised.

Strong GWP growth, acceptable ex-cat COR’s, very strong investment income driving robust ROE’s. Retention rates remain close to 90%, so higher pricing, and higher volumes, are not leading to higher churn rates.

The balance sheet remains strong, and with QBE trading at 10x forward earnings, we think we are compensated for this required uplift in earnings as regards the outlook.

The longer-run earnings outlook seems very strong, given these broader rate and volume drivers, including additional lines of business (e.g. cyber) or opportunities for cost out (AI).

All those analyst PT’s above basically amount to “well, if we take it at face value (mgmt answers/commentary) which seemed/sounded plausible, it should be fine, but, hurdles are hurdles. However, it’s on 10x so how bad does it have to be”.

With that balance in mind, we are sufficiently comfortable.

Important Information: This document has been prepared by Aequitas Investment Partners ABN 92 644 165 266 (“Aequitas”, “our”, “we”), a Corporate Authorised Representative (no. 1284389) of C2 Financial Services, (Australian Financial Services Licensee no. 502171), and is for distribution within Australia to wholesale clients and financial advisers only.

This document is based on information available at the time of publishing, information which we believe is correct and any opinions, conclusions or forecasts are reasonably held or made as at the time of its compilation, but no warranty is made as to its accuracy, reliability or completeness. To the extent permitted by law, neither Aequitas nor any of its affiliates accept liability to any person for loss or damage arising from the use of the information herein.

Please note that past performance is not a reliable indicator of future performance.

General Advice Warning: This document has been prepared without taking into account your objectives, financial situation or needs, and therefore you should consider its appropriateness, having regard to your objectives, financial situation and needs. Before making any decision about whether to acquire a financial product, you should obtain and read the relevant Product Disclosure Statement (PDS) or Investor Directed Portfolio Service Guide (IDPS Guide) and consider talking to a financial adviser.

Taxation warning: Any taxation considerations are general and based on present taxation laws and may be subject to change. Aequitas is not a registered tax (financial) adviser under the Tax Agent Services Act 2009 and investors should seek tax advice from a registered tax agent or a registered tax (financial) adviser if they intend to rely on this information to satisfy the liabilities or obligations or claim entitlements that arise, or could arise, under a taxation law.

Receive our investment insights

Something went wrong. Please check your entries and try again.